{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T11:26:22Z","timestamp":1793618782612,"version":"4.5.0"},"reference-count":37,"publisher":"Becaris Publishing Limited","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Comp. Eff. Res."],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:p>\n                    <jats:bold>Aim:<\/jats:bold>\n                    To develop, implement and evaluate a living network meta-analysis (NMA) framework for comparative effectiveness research, using chronic venous insufficiency treatment as a case study. The framework addresses key barriers to sustained evidence synthesis: resource sustainability, methodological consistency and transparent dissemination.\n                    <jats:bold>Materials &amp; methods:<\/jats:bold>\n                    A four-phase living NMA framework was established with prospective protocol registration, quarterly literature surveillance and annual update cycles. The baseline systematic review, registered in PROSPERO, searched English-language publications (2000\u20132023) per PRISMA guidelines. Eligible studies included randomized and non-randomized comparisons of polidocanol 1% endovenous microfoam (PEM) or endovenous thermal ablation versus any comparator. Network connectivity relied on common comparators (surgery, physician-compounded foam) and head-to-head PEM versus endovenous thermal ablation studies. The protocol specifies predetermined eligibility criteria, standardized data extraction and consistent statistical methods, with results posted to a publicly accessible website.\n                    <jats:bold>Results:<\/jats:bold>\n                    The baseline NMA (13 studies; 233,801 patients) was published in a peer-reviewed journal and simultaneously posted publicly. The first update identified seven new eligible studies, expanding the evidence base to 20 studies and 235,093 patients. Effect estimates remained stable with no change in primary conclusions, demonstrating robustness to new evidence incorporation. Update-cycle workload was substantially less than the initial NMA effort, with efficiency gains attributable to team continuity, accrued clinical expertise and stable data definitions.\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    This living NMA framework balances scientific rigor with practical sustainability through industry partnership and transparent dissemination. The successful first update confirms feasibility, though the framework was developed with a single sponsor in one clinical area and transferability to other contexts has not been tested.\n                  <\/jats:p>","DOI":"10.57264\/cer-2026-0142","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T11:38:28Z","timestamp":1791459508000},"source":"Crossref","is-referenced-by-count":0,"title":["Development and implementation of a living network meta-analysis framework for comparative effectiveness research: a case study in chronic venous insufficiency treatment"],"prefix":"10.57264","volume":"15","author":[{"given":"Wendy","family":"Wifler","sequence":"first","affiliation":[{"name":"Boston Scientific, Maple Grove, MN 55311, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Sutherland","sequence":"additional","affiliation":[{"name":"Boston Scientific, Maple Grove, MN 55311, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Frame","sequence":"additional","affiliation":[{"name":"Frame Research LLC, Brooklyn, NY 11215, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry","family":"Gache","sequence":"additional","affiliation":[{"name":"LGache Statistical Consulting, LLC, Oakwood, OH 45419, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0723-585X","authenticated-orcid":false,"given":"Candace","family":"Gunnarsson","sequence":"additional","affiliation":[{"name":"Gunnarsson Consulting, Boise, ID 83703, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"36897","reference":[{"issue":"4","key":"e_1_3_7_3_2","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7326\/0003-4819-147-4-200708210-00179","article-title":"How quickly do systematic reviews go out of date? A survival analysis","volume":"147","author":"Shojania KG","year":"2007","unstructured":"Shojania KG, Sampson M, Ansari MT, Ji J, Doucette S, Moher D. How quickly do systematic reviews go out of date? A survival analysis. Ann. Intern. Med. 147(4), 224\u2013233 (2007).","journal-title":"Ann. Intern. Med."},{"key":"e_1_3_7_4_2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jclinepi.2017.08.010","article-title":"Living systematic review: 1. Introduction\u2014the why, what, when, and how","volume":"91","author":"Elliott JH","year":"2017","unstructured":"Elliott JH, Synnot A, Turner T Living systematic review: 1. Introduction\u2014the why, what, when, and how. J. Clin. Epidemiol. 91, 23\u201330 (2017).","journal-title":"J. Clin. Epidemiol."},{"issue":"2","key":"e_1_3_7_5_2","doi-asserted-by":"crossref","first-page":"e1001603","DOI":"10.1371\/journal.pmed.1001603","article-title":"Living systematic reviews: an emerging opportunity to narrow the evidence-practice gap","volume":"11","author":"Elliott JH","year":"2014","unstructured":"Elliott JH, Turner T, Clavisi O Living systematic reviews: an emerging opportunity to narrow the evidence-practice gap. PLoS Med. 11(2), e1001603 (2014).","journal-title":"PLoS Med."},{"key":"e_1_3_7_6_2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jclinepi.2018.12.008","article-title":"Living network meta-analysis was feasible when considering the pace of evidence generation","volume":"108","author":"Cr\u00e9quit P","year":"2019","unstructured":"Cr\u00e9quit P, Martin-Montoya T, Attiche N, Trinquart L, Vivot A, Ravaud P. Living network meta-analysis was feasible when considering the pace of evidence generation. J. Clin. Epidemiol. 108, 10\u201316 (2019).","journal-title":"J. Clin. Epidemiol."},{"key":"e_1_3_7_7_2","doi-asserted-by":"crossref","first-page":"f2914","DOI":"10.1136\/bmj.f2914","article-title":"Demystifying trial networks and network meta-analysis","volume":"346","author":"Mills EJ","year":"2013","unstructured":"Mills EJ, Thorlund K, Ioannidis JP. Demystifying trial networks and network meta-analysis. BMJ 346, f2914 (2013).","journal-title":"BMJ"},{"key":"e_1_3_7_8_2","doi-asserted-by":"crossref","first-page":"111904","DOI":"10.1016\/j.jclinepi.2025.111904","article-title":"Capturing the influx of living systematic reviews: a systematic methodological survey","volume":"186","author":"Nevill CR","year":"2025","unstructured":"Nevill CR, Sharifan A, O'Mahony A Capturing the influx of living systematic reviews: a systematic methodological survey. J. Clin. Epidemiol. 186, 111904 (2025).","journal-title":"J. Clin. Epidemiol."},{"issue":"11","key":"e_1_3_7_9_2","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.2105\/AJPH.2020.305920","article-title":"Living systematic reviews and other approaches for updating evidence","volume":"110","author":"Lansky A","year":"2020","unstructured":"Lansky A, Wethington H. Living systematic reviews and other approaches for updating evidence. Am. J. Public Health 110(11), 1687\u20131688 (2020).","journal-title":"Am. J. Public Health"},{"issue":"6","key":"e_1_3_7_10_2","doi-asserted-by":"crossref","first-page":"101896","DOI":"10.1016\/j.jvsv.2024.101896","article-title":"Comparative effectiveness of non-compounded polidocanol 1% endovenous microfoam (Varithena) ablation versus endovenous thermal ablation utilizing a systematic review and network meta-analysis","volume":"12","author":"Kabnick LS","year":"2024","unstructured":"Kabnick LS, Jimenez JC, Coogan SM Comparative effectiveness of non-compounded polidocanol 1% endovenous microfoam (Varithena) ablation versus endovenous thermal ablation utilizing a systematic review and network meta-analysis. J. Vasc. Surg. Venous Lymphat. Disord. 12(6), 101896 (2024).","journal-title":"J. Vasc. Surg. Venous Lymphat. Disord."},{"issue":"4","key":"e_1_3_7_11_2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1177\/0268355515589063","article-title":"Benefits of polidocanol endovenous microfoam (Varithena) compared with physician-compounded foams","volume":"31","author":"Carugo D","year":"2016","unstructured":"Carugo D, Ankrett DN, Zhao X Benefits of polidocanol endovenous microfoam (Varithena) compared with physician-compounded foams. Phlebology 31(4), 283\u2013295 (2016).","journal-title":"Phlebology"},{"issue":"3","key":"e_1_3_7_12_2","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1177\/0268355516687864","article-title":"Novel developments in foam sclerotherapy: focus on Varithena (polidocanol endovenous microfoam) in the management of varicose veins","volume":"33","author":"Star P","year":"2018","unstructured":"Star P, Connor DE, Parsi K. Novel developments in foam sclerotherapy: focus on Varithena (polidocanol endovenous microfoam) in the management of varicose veins. Phlebology 33(3), 150\u2013162 (2018).","journal-title":"Phlebology"},{"key":"e_1_3_7_13_2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2105\/AJPH.2023.307450","article-title":"Living systematic reviews and living guidelines to maintain the currency of public health guidelines","volume":"114","author":"Hodder RK","year":"2024","unstructured":"Hodder RK, Vogel JP, Wolfenden L, Turner T. Living systematic reviews and living guidelines to maintain the currency of public health guidelines. Am. J. Public Health 114, 21\u201326 (2024).","journal-title":"Am. J. Public Health"},{"key":"e_1_3_7_14_2","unstructured":"Gunnarsson C Frame D Gache L. Effectiveness of polidocanol microfoam (Varithena) for the treatment of chronic venous insufficiency. PROSPERO 2023 CRD42023406807. (Accessed 18 June 2026). https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42023406807"},{"key":"e_1_3_7_15_2","unstructured":"Brooker J Synnot A McDonald S Guidance for the production and publication of Cochrane living systematic reviews: cochrane reviews in living mode. (2019) (Accessed 20 February 2026). https:\/\/resources.cochrane.org\/sites\/resources.cochrane.org\/files\/uploads\/inline-files\/Transform\/201912_LSR_Revised_Guidance.pdf"},{"key":"e_1_3_7_16_2","doi-asserted-by":"crossref","DOI":"10.1002\/9781119536604","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins JPT","year":"2019","unstructured":"Higgins JPT, Thomas J, Chandler Jet al. (Eds). Cochrane Handbook for Systematic Reviews of Interventions. 2nd Edition. John Wiley & Sons, NJ, US, (2019).","edition":"2"},{"key":"e_1_3_7_17_2","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372, n71 (2021).","journal-title":"BMJ"},{"key":"e_1_3_7_18_2","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton B","year":"2015","unstructured":"Hutton B, Salanti G, Caldwell DM The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann. Intern. Med. 162, 777\u2013784 (2015).","journal-title":"Ann. Intern. Med."},{"key":"e_1_3_7_19_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad AR","year":"1996","unstructured":"Jadad AR, Moore RA, Carroll D Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control. Clin. Trials 17, 1\u201312 (1996).","journal-title":"Control. Clin. Trials"},{"key":"e_1_3_7_20_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v106.i02","article-title":"netmeta: an R package for network meta-analysis using frequentist methods","volume":"106","author":"Balduzzi S","year":"2023","unstructured":"Balduzzi S, R\u00fccker G, Nikolakopoulou A netmeta: an R package for network meta-analysis using frequentist methods. J. Stat. Softw. 106, 1\u201340 (2023).","journal-title":"J. Stat. Softw."},{"issue":"7","key":"e_1_3_7_21_2","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/sim.3767","article-title":"Checking consistency in mixed treatment comparison meta-analysis","volume":"29","author":"Dias S","year":"2010","unstructured":"Dias S, Welton NJ, Caldwell DM, Ades AE. Checking consistency in mixed treatment comparison meta-analysis. Stat. Med. 29(7\u20138), 932\u2013944 (2010).","journal-title":"Stat. Med."},{"key":"e_1_3_7_22_2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-2288-13-35","article-title":"A graphical tool for locating inconsistency in network meta-analyses","volume":"13","author":"Krahn U","year":"2013","unstructured":"Krahn U, Binder H, K\u00f6nig J. A graphical tool for locating inconsistency in network meta-analyses. BMC Med. Res. Methodol. 13, 35 (2013).","journal-title":"BMC Med. Res. Methodol."},{"issue":"9","key":"e_1_3_7_23_2","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1177\/02683555221125384","article-title":"Efficiency of endovenous laser and glue ablation methods in comparison with conventional surgery for the treatment of venous ulcers","volume":"37","author":"Erdinc I","year":"2022","unstructured":"Erdinc I. Efficiency of endovenous laser and glue ablation methods in comparison with conventional surgery for the treatment of venous ulcers. Phlebology 37(9), 670\u2013677 (2022).","journal-title":"Phlebology"},{"issue":"7","key":"e_1_3_7_24_2","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1177\/15385744231173192","article-title":"Comparison of radiofrequency ablation and saphenous vein stripping for the treatment of recurrent lower extremity venous insufficiency","volume":"57","author":"Kanber EM","year":"2023","unstructured":"Kanber EM, Cetin HK. Comparison of radiofrequency ablation and saphenous vein stripping for the treatment of recurrent lower extremity venous insufficiency. Vasc. Endovascular Surg. 57(7), 726\u2013731 (2023).","journal-title":"Vasc. Endovascular Surg."},{"issue":"2","key":"e_1_3_7_25_2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/17085381211011356","article-title":"Comparison of high saphenous ligation and stripping, radiofrequency ablation, and subfascial endoscopic perforator surgery for the treatment of active venous ulcers: retrospective cohort with five-year follow-up","volume":"30","author":"Kuserli Y","year":"2022","unstructured":"Kuserli Y, Kavala AA, Turkyilmaz S. Comparison of high saphenous ligation and stripping, radiofrequency ablation, and subfascial endoscopic perforator surgery for the treatment of active venous ulcers: retrospective cohort with five-year follow-up. Vascular 30(2), 375\u2013383 (2022).","journal-title":"Vascular"},{"issue":"35","key":"e_1_3_7_26_2","doi-asserted-by":"crossref","first-page":"8291","DOI":"10.12998\/wjcc.v11.i35.8291","article-title":"Endovenous laser treatment vs conventional surgery for great saphenous vein varicosities: a propensity score matching analysis","volume":"11","author":"Li Q","year":"2023","unstructured":"Li Q, Zhang C, Yuan Z, Shao ZQ, Wang J. Endovenous laser treatment vs conventional surgery for great saphenous vein varicosities: a propensity score matching analysis. World J. Clin. Cases 11(35), 8291\u20138299 (2023).","journal-title":"World J. Clin. Cases"},{"issue":"2","key":"e_1_3_7_27_2","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jvsv.2021.08.013","article-title":"Ultrasound-assisted varicose vein surgery and endovenous laser ablation using 1470-nm laser for treatment of great saphenous vein incompetence has similar outcomes at 1 year in a single-center prospective randomized study","volume":"10","author":"Rajendran S","year":"2022","unstructured":"Rajendran S, Nair HR, Irshad KM, Unais TM, Thaikattil NJ. Ultrasound-assisted varicose vein surgery and endovenous laser ablation using 1470-nm laser for treatment of great saphenous vein incompetence has similar outcomes at 1 year in a single-center prospective randomized study. J. Vasc. Surg. Venous Lymphat. Disord. 10(2), 370\u2013375 (2022).","journal-title":"J. Vasc. Surg. Venous Lymphat. Disord."},{"issue":"6","key":"e_1_3_7_28_2","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.jvsv.2023.06.015","article-title":"Quantifiable remaining reflux 1 year after treatment of superficial venous incompetence is associated with impaired clinical outcome","volume":"11","author":"Skoog J","year":"2023","unstructured":"Skoog J, Zachrisson H, Nelz\u00e9n POE. Quantifiable remaining reflux 1 year after treatment of superficial venous incompetence is associated with impaired clinical outcome. J. Vasc. Surg. Venous Lymphat. Disord. 11(6), 1130\u20131138 (2023).","journal-title":"J. Vasc. Surg. Venous Lymphat. Disord."},{"issue":"5","key":"e_1_3_7_29_2","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.jvsv.2023.03.015","article-title":"Comparison of outcomes following polidocanol microfoam and radiofrequency ablation of incompetent thigh great and accessory saphenous veins","volume":"11","author":"Talutis SD","year":"2023","unstructured":"Talutis SD, Chin AL, Lawrence PF, Woo K, Jimenez JC. Comparison of outcomes following polidocanol microfoam and radiofrequency ablation of incompetent thigh great and accessory saphenous veins. J. Vasc. Surg. Venous Lymphat. Disord. 11(5), 916\u2013920 (2023).","journal-title":"J. Vasc. Surg. Venous Lymphat. Disord."},{"issue":"4","key":"e_1_3_7_30_2","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jvsv.2023.03.014","article-title":"Early results following comparison of radiofrequency and microfoam ablation of large diameter truncal veins demonstrate high closure rates and symptomatic relief","volume":"11","author":"Chin AL","year":"2023","unstructured":"Chin AL, Talutis SD, Lawrence PF, Jimenez JC. Early results following comparison of radiofrequency and microfoam ablation of large diameter truncal veins demonstrate high closure rates and symptomatic relief. J. Vasc. Surg. Venous Lymphat. Disord. 11(4), 716\u2013722 (2023).","journal-title":"J. Vasc. Surg. Venous Lymphat. Disord."},{"issue":"3","key":"e_1_3_7_31_2","doi-asserted-by":"crossref","first-page":"101815","DOI":"10.1016\/j.jvsv.2024.101815","article-title":"Factors associated with ablation-related thrombus extension following microfoam versus radiofrequency saphenous vein closure","volume":"12","author":"Chin AL","year":"2024","unstructured":"Chin AL, Talutis SD, Lawrence PF Factors associated with ablation-related thrombus extension following microfoam versus radiofrequency saphenous vein closure. J. Vasc. Surg. Venous Lymphat. Disord. 12(3), 101815 (2024).","journal-title":"J. Vasc. Surg. Venous Lymphat. Disord."},{"issue":"2","key":"e_1_3_7_32_2","doi-asserted-by":"crossref","first-page":"101690","DOI":"10.1016\/j.jvsv.2023.09.004","article-title":"Increased body mass index and vein diameter are associated with incomplete target vein closure following microfoam ablation of incompetent saphenous veins","volume":"12","author":"Talutis SD","year":"2024","unstructured":"Talutis SD, Chin AL, Lawrence PF Increased body mass index and vein diameter are associated with incomplete target vein closure following microfoam ablation of incompetent saphenous veins. J. Vasc. Surg. Venous Lymphat. Disord. 12(2), 101690 (2024).","journal-title":"J. Vasc. Surg. Venous Lymphat. Disord."},{"issue":"8","key":"e_1_3_7_33_2","first-page":"455","article-title":"Treatment patterns and outcomes in patients with varicose veins","volume":"9","author":"Mallick R","year":"2016","unstructured":"Mallick R, Raju A, Campbell C Treatment patterns and outcomes in patients with varicose veins. Am. Health Drug Benefits 9(8), 455\u2013465 (2016).","journal-title":"Am. Health Drug Benefits"},{"issue":"6","key":"e_1_3_7_34_2","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.jvsv.2021.04.015","article-title":"Extended Center for Vein Restoration study assessing comparative outcomes for the treatment of chronic venous insufficiency in Medicare- and non-Medicare-eligible patients","volume":"9","author":"Pappas PJ","year":"2021","unstructured":"Pappas PJ, Lakhanpal S, Nguyen KQ, Fernandez E, Sufian S. Extended Center for Vein Restoration study assessing comparative outcomes for the treatment of chronic venous insufficiency in Medicare- and non-Medicare-eligible patients. J. Vasc. Surg. Venous Lymphat. Disord. 9(6), 1426\u20131436 (2021).","journal-title":"J. Vasc. Surg. Venous Lymphat. Disord."},{"key":"e_1_3_7_35_2","unstructured":"Boston Scientific Corporation. Varithena: a living network meta-analysis. (2026) (Accessed 20 February 2026). https:\/\/www.varithena.com\/en-us-hcp\/clinical-evidence\/living-meta-analysis.html"},{"issue":"1","key":"e_1_3_7_36_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher D","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst. Rev. 4(1), 1 (2015).","journal-title":"Syst. Rev."},{"issue":"2","key":"e_1_3_7_37_2","first-page":"MR000033","article-title":"Industry sponsorship and research outcome","volume":"2","author":"Lundh A","year":"2017","unstructured":"Lundh A, Lexchin J, Mintzes B, Schroll JB, Bero L. Industry sponsorship and research outcome. Cochrane Database Syst. Rev. 2(2), MR000033 (2017).","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"e_1_3_7_38_2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13643-023-02235-z","article-title":"Does type of funding affect reporting in network meta-analysis? A scoping review of network meta-analyses","volume":"12","author":"Veroniki AA","year":"2023","unstructured":"Veroniki AA, Wong EKC, Lunny C Does type of funding affect reporting in network meta-analysis? A scoping review of network meta-analyses. Syst. Rev. 12(1), 81 (2023).","journal-title":"Syst. Rev."},{"key":"e_1_3_7_39_2","first-page":"42","article-title":"Automating risk of bias assessment in systematic reviews: a real-time machine learning approach","volume":"157","author":"Marshall IJ","year":"2023","unstructured":"Marshall IJ, Nye B, Kuber J Automating risk of bias assessment in systematic reviews: a real-time machine learning approach. J. Clin. Epidemiol. 157, 42\u201352 (2023).","journal-title":"J. Clin. Epidemiol."}],"container-title":["Journal of Comparative Effectiveness Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/becarispublishing.com\/doi\/pdf\/10.57264\/cer-2026-0142","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T10:34:22Z","timestamp":1793615662000},"score":1,"resource":{"primary":{"URL":"https:\/\/becarispublishing.com\/doi\/10.57264\/cer-2026-0142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["10.57264\/cer-2026-0142"],"URL":"https:\/\/doi.org\/10.57264\/cer-2026-0142","relation":{},"ISSN":["2042-6305","2042-6313"],"issn-type":[{"value":"2042-6305","type":"print"},{"value":"2042-6313","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,11]]},"article-number":"e260142"}}